Improving Clinical Trial Access And The Positive Impacts On Patient Recruitment

Traveling to and from trial sites significantly burdens clinical trial participants. Sites, sponsors, and professionals involved in managing clinical trials understand that reducing the distance patients travel to participate in a trial significantly improves retention.

20/20 Onsite provides solutions to accelerate enrollment, improve timelines, and increase patient retention for clinical trials with ophthalmic endpoints. Delivering care across 48 states, 20/20 Onsite reduces the average distance study participants need to travel from 67 to 12.36 miles.